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Identification of new genes involved in biofilm formation is needed to understand the molecular basis of
strain variation and the pathogenic mechanisms implicated in chronic staphylococcal infections. A biofilm-
producing Staphylococcus aureus isolate was used to generate biofilm-negative transposon (Tn917) insertion
mutants. Two mutants were found with a significant decrease in attachment to inert surfaces (early adherence),
intercellular adhesion, and biofilm formation. The transposon was inserted at the same locus in both mutants.
This locus (bap [for biofilm associated protein]) encodes a novel cell wall associated protein of 2,276 amino
acids (Bap), which shows global organizational similarities to surface proteins of gram-negative (Pseudomonas
aeruginosa and Salmonella enterica serovar Typhi) and gram-positive (Enteroccocus faecalis) microorganisms.
Bap’s core region represents 52% of the protein and consists of 13 successive nearly identical repeats, each
containing 86 amino acids. bap was present in a small fraction of bovine mastitis isolates (5% of the 350 S.
aureus isolates tested), but it was absent from the 75 clinical human S. aureus isolates analyzed. All staphy-
lococcal isolates harboring bap were highly adherent and strong biofilm producers. In a mouse infection model
bap was involved in pathogenesis, causing a persistent infection.
Staphylococcus aureus is one of the most important patho-
gens in humans and animals. The pathogenesis of a particular
S. aureus strain is attributed to the combined effect of extra-
cellular factors and toxins, together with the invasive proper-
ties of the strain such as adherence, biofilm formation, and
resistance to phagocytosis. Despite general agreement that
biofilms are the basis for persistent or chronic bacterial infec-
tions (8), the understanding of the molecular mechanisms im-
plicated in the biofilm formation process is still growing (39).
Two steps appear to be involved in this process: (i) attachment
of the bacterial cells to a surface (early adherence) and (ii)
growth-dependent accumulation of bacteria in multilayered
cell clusters (intercellular adhesion) (18). Different proteins
(24, 37), including those of the family of microbial surface
components that recognize adhesive matrix molecules
(MSCRAMMs) (13), are involved in S. aureus adhesion. Spe-
cifically, MSCRAMMs may mediate S. aureus attachment to
different cell types (11, 44) and abiotic surfaces once the ad-
hesive host plasma constituents have covered the target surface
(10, 29). However, the possible role of known MSCRAMMs or
other molecules on the binding of S. aureus to inert surfaces in
the absence of host constituents has not been thoroughly stud-
ied so far.
The icaABCD cluster, an operon present in Staphylococcus
epidermidis and S. aureus (9, 20), participates in the intercel-
lular adhesion step of biofilm formation by encoding proteins
involved in the synthesis of the biofilm matrix polysaccharide
poly-N-succinyl b-1-6 glucosamine (PIA-PNSG). The implica-
tion of ica in staphylococcal pathogenesis has been demon-
strated in various animal models (30, 40). A relationship has
been shown in vivo between the expression of ica in clinical S.
epidermidis strains and infection (15). In addition, immuniza-
tions with PIA-PNSG efficiently protect against S. aureus in-
fection (30).
Considerable effort has been made by different groups to
associate S. aureus biofilm formation with different mecha-
nisms of virulence and pathogenesis. In this context and using
highly adherent strains, we have observed that S. aureus in vitro
adherence and biofilm formation on inert or mammalian cell
surfaces is associated with (i) exopolysaccharide production (6,
23); (ii) rough colony morphology phenotype in Congo red
agar (CRA) (6); (iii) higher resistance to phagocytosis (32);
(iv) lower susceptibility to antibiotics when forming biofilms
(2); (v) higher capacity to attach to different surfaces and
biomaterials used in orthopedic surgery, causing osteomyelitis
(16); and (vi) higher capacity to colonize the ovine mammary
gland, causing mastitis (6). In addition, active immunizations
with exopolysaccharides extracted from a highly adherent S.
aureus isolate have been shown to trigger protective immunity
against mastitis (3). However, the genetic mechanisms under-
lying these observations have not been determined.
Transposon mutagenesis has been used to determine the
genetics of biofilm formation in different bacterial species,
including S. epidermidis (18, 33), Streptococcus gordonii (26),
Escherichia coli (38), Pseudomonas fluorescens (36), and Pseudo-
monas aeruginosa (35), using polystyrene microtiter plates as
substrate. With this methodological approach, we were able to
identify in this study a new protein which is involved in S.
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aureus attachment to abiotic surfaces and biofilm formation in
vitro and enhances infection in vivo.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and plasmids. In order to find a strong
biofilm forming strain, the ability of 350 S. aureus mastitis isolates to attach and
form a biofilm on polystyrene microtiter plates was tested as previously described
(9). Accordingly, a bovine subclinical mastitis isolate, S. aureus V329, was se-
lected because of its strong biofilm production phenotype and antibiotic suscep-
tibility profile, which facilitates genetic manipulations. This isolate was used to
generate a genomic library and to obtain biofilm-negative transposon insertion
mutants. S. aureus SA113, a restriction-negative and biofilm producer strain, and
the biofilm-defective S. aureus SA113Dica, which contains a tetracycline resis-
tance cassette that replaces the ica genes, were kindly provided by F. Go¨tz (9).
S. aureus RN4220, a restriction-negative strain, unable to form a biofilm, was
kindly provided by J. C. Lee. Seventy-five human S. aureus strains and 50 coag-
ulase-negative Staphylococcus strains from animals with bovine mastitis were
analyzed for the presence of bap.
Staphylococcal strains were cultured in Trypticase soy agar (TSA) and in
trypticase soy broth (TSB) supplemented with glucose (0.25%, wt/vol) when
indicated. B2 broth (42) was used for biofilm formation on a glass surface. E. coli
strains DH5a and BL21(DE3) were grown in Luria-Bertani medium. Media
were supplemented when appropriate with erythromycin (20 mg/ml), ampicillin
(50 mg/ml) and chloramphenicol (10 mg/ml for plasmid pBT2 [7] and 20 mg/ml
for plasmid pID408 [31]). Plasmid pID408 contains the transposon Tn917, which
includes the pBR322 amp or rop region that allows replication and selection of
the plasmid in E. coli, and the temperature-sensitive replicon pE194ts and the
Cmr gene of pTV32ts that allows replication and selection in S. aureus at 32°C.
Plasmid pET-15b (Novagen) was used for protein expression in E. coli. The
lambda vector EMBL-4 (Promega) was used to obtain a genomic library.
DNA manipulations. Routine DNA manipulations were performed using stan-
dard procedures (41). Plasmid DNA was isolated from S. aureus strains using a
Qiagen plasmid miniprep kit according to the manufacturer’s protocol, except
that the bacterial cells were lysed by lysostaphin (12.5 mg/ml; Sigma) at 37°C for
2 h before plasmid purification. Plasmids were transformed into staphylococci by
electroporation, using a previously described procedure (25) with the following
modifications: 10% glycerol was replaced by 0.5 M sucrose, and staphylococcal
transformations were enhanced by inducing chloramphenicol acetyl transferase
translation with subinhibitory concentrations of chloramphenicol (0.2 mg/ml)
after electroporation.
For Southern hybridization, chromosomal DNA was purified as previously
described (28), digested with EcoRI, and analyzed by agarose gel electrophore-
sis. Gels were blotted onto nylon membranes (Hybond-N 0.45-mm-pore-size
filters; Amersham Life Science) using standard methods (41). A 971-bp PCR
fragment (oligonucleotides bap-6m, 59-CCCTATATCGAAGGTGTAGAATTG
CAC-39 [1807], and bap-7c, 59-GCTGTTGAAGTTAATACTGTACCTGC-39
[2777]) of the bap region was used as a DNA probe (numbers in parentheses
correspond to the position in the gene of the first nucleotide contained in the
PCR fragment). Labeling of the probe and DNA hybridization were performed
according to the protocol supplied with the PCR-DIG DNA-labeling and chemi-
luminescence detection kit (Roche).
All the enzymes for DNA manipulation were supplied by MBI Fermentas,
Roche, and Amersham Pharmacia Biotech; assays were performed as recom-
mended by the manufacturer. Oligonucleotide primers were purchased from Life
Technologies.
Transposon mutagenesis. S. aureus strain V329 harboring pID408 (V329:
pID408) was grown overnight in TSA-chloramphenicol at 30°C. A single colony
of V329:pID408 was inoculated in 1 ml of TSB-chloramphenicol (5 mg/ml) and
incubated for 1 h at 30°C. Subsequently, 100 ml of this culture were spread on
TSA-erythromycin plates and incubated for 18 h at 44°C. Transposon insertion
mutants were subcultured on TSA-erythromycin plates. To exclude the possibil-
ity of contamination, mutants were compared with the parental strain by coag-
ulase DNA typing (21).
Adherence studies. (i) Early adherence to an inert surface. Early adherence to
a polystyrene surface was determined as previously described (14), with the
following modifications. S. aureus strains were grown overnight in TSB supple-
mented with 0.25% glucose at 37°C. Overnight cultures were adjusted with
TSB–0.25% glucose to an optical density at 578 nm (OD578) of 0.1. Ten milliliters
of each suspension was added to two polystyrene petri dishes and incubated for
1 h at 37°C. Petri dishes were washed at least five times with phosphate-buffered
saline (PBS). Cells were fixed with Bouin solution and Gram stained. Adherent
bacterial cells were observed by oil immersion microscopy and counted (results
represent the means of four different microscopic fields). Each experiment was
repeated three times.
(ii) Biofilm assay. A late adherence assay was carried out essentially as de-
scribed elsewhere (18). Briefly, S. aureus strains were grown overnight in TSB at
37°C. The culture was diluted 1:40 in TSB–0.25% glucose, and 200 ml of this cell
suspension was used to inoculate sterile 96-well polystyrene microtiter plates
(lwaki). After 12 h, medium was replaced, and 12 h later, the wells were gently
washed three times with 200 ml of sterile PBS, dried in an inverted position, and
stained with 0.1% safranin for 30 s. Wells were rinsed again, and the absorbance
was determined at 490 nm (Micro-ELISA Autoreader; Elx800 Bio-Tek instru-
ments). Each assay was performed in triplicate and repeated five times.
Verification of the classification of strains as biofilm producers and nonpro-
ducers was carried out by different methods.
(a) Formation of cell aggregates in a cell suspension. Cells were grown over-
night in 5 ml of TSB–0.25% glucose at 37°C and examined macroscopically and
microscopically for the presence or absence of aggregates (intercellular adhe-
sion).
(b) Macroscopic observation of biofilm on glass. Cells were grown in 50 ml of
B2 at 37°C, using a glass container, without shaking, for 2 days, and the walls of
the container were visually (macroscopically) examined for the presence or
absence of a white biofilm layer.
(c) Colonization of other materials. The capacity to form a biofilm layer was
verified using polyvinylchloride (PVC) plastic as a target surface and a phase-
contrast microscope (magnification, 31,000; Nikon Optiphot-2 microscope), as
previously described (38).
(d) Colony morphology in CRA. Colony morphology was determined in CRA
as previously described (6, 48), with rough colonies being indicative of biofilm
formation (positive result) and smooth colonies being associated with a defi-
ciency in biofilm formation.
PIA-PNSG detection. PIA-PNSG production in S. aureus was detected as
described by Cramton et al. (9). Briefly, cells were grown overnight in TSB
supplemented with 0.25% glucose, the optical density was determined, and the
same number of cells (2 to 4 ml) from each culture was resuspended in 50 ml of
0.5 M EDTA (pH 8.0). Cells were then incubated for 5 min at 100°C and
centrifuged to pellet the cells, and 40 ml of the supernatant was incubated with
10 ml of proteinase K (20 mg/ml; Sigma) for 30 min at 37°C. After addition of 10
ml of Tris-buffered saline (20 mM Tris-HCl, 150 mM NaCl [pH 7.4]) containing
0.01% bromophenol blue, 10 ml was spotted on a nitrocellulose filter using a
Bio-Dot Microfiltration apparatus (Bio-Rad), blocked overnight with 5% skim
milk in PBS with 0.1% Tween 20, and incubated for 2 h with an anti-S. aureus
PIA-PNSG antibody diluted 1:10,000 (30). Bound antibodies were detected with
a peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (Jackson
ImmunoResearch Laboratories, Inc.) diluted 1:10,000, and the Amersham ECL
(enhanced chemiluminescence) Western blotting system.
Gene identification. A previously described method (31) was used to clone the
chromosomal DNA flanking the transposon insertion points in mutants with
attenuated biofilm production. Briefly, 2.5 mg of S. aureus chromosomal DNA
from each mutant was restricted with EcoRI, resuspended in 200 ml of ligation
buffer (Promega), and self-ligated for 12 h at 16°C. The ligated products were
transformed into E. coli DH5a, plated onto Luria-Bertani agar containing am-
picillin, and incubated at 37°C overnight. Plasmid DNA was extracted from a
single ampicillin-resistant colony using a Qiagen plasmid miniprep kit. Chromo-
somal DNA sequences flanking the transposon were obtained using primer
Tn917-3c (59-AGAGAGATGTCACCGTCAAGT-39), which corresponds to the
inverted repeat region located 70 bp from the erm-proximal end of Tn917.
Construction of genomic library. The lambda vector EMBL-4 was used to
construct a genomic library of S. aureus V329 according to the manufacturer’s
instructions (Promega). Chromosomal DNA of S. aureus V329 was digested with
EcoRI and ligated into vector EMBL-4 restricted with EcoRI. A 200-bp PCR
fragment of the bap flanking region was used as a DNA probe (oligonucleotides
556-1m, 59-CTGTCCATATTTGGACTGTG-39, and 556-2c, 59-CTTATAGAT
GTGCGTAGTC-39). Labeling of the probe and DNA hybridization were per-
formed according to the protocol supplied with the PCR-DIG DNA-labeling and
chemiluminescence detection kit (Roche).
DNA sequencing and computer analysis. A genomic HindIII fragment includ-
ing the bap gene was cloned in pBT2 plasmid (pBT2:Bap). The nucleotide
sequence was determined by the dideoxy chain termination method, using an
ABl 377 model automatic sequencer (PE Biosystems; Foster City, Calif.) at the
DNA Sequencing Service of the IBMCP-UPV (Valencia, Spain). For C-repeat
sequencing, a genomic DNA XbaI-EcoRI fragment containing this region was
subcloned in pBT2. Nested deletions were generated (Erase-a-base system; Pro-
mega). Double DNA sequencing of this region was carried out using the primers
pBT2-1c (59-GGACGATATCCCGCAAGAGGCCCG-39) and pBT2-2c (59-GG
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TGCCGAGGATGACGATGAGCGC-39), corresponding to the flanking region
of the plasmid pBT2 cloning site.
Homology searches were carried out using the BLAST 2.0 program (1) at the
NCBl server. The cloned sequence was compared against those in the GenBank
database and the publicly available S. aureus genomes (The Institute for
Genomic Research, University of Oklahoma, and Sanger Centre).
Complementation studies. To prove that the biofilm-deficient phenotype of
the mutants was due to the disruption of bap, mutants were complemented with
plasmid pBT2 carrying a 9.2 kb HindIII fragment from the wild-type strain,
including the bap gene under the control of its own promoter (pBT2:Bap).
Plasmid pBT2:Bap was transformed by electroporation into S. aureus strains
m556, RN4220, SA113, and SA113Dica. Stable expression of Bap was analyzed
in total bacterial extracts by Coomassie staining of proteins run on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels.
SDS-PAGE and Western blot analysis. Bacteria were grown overnight in TSB
(supplemented with 10 mg of chloramphenicol/ml in the case of complemented
strains) at 30°C. Following centrifugation of 1 ml of culture, cells were harvested,
washed, and finally resuspended in 75 ml of PBS buffer containing lysostaphin
(12.5 mg/ml; Sigma). After 2 h of incubation at 37°C, cells were resuspended in
1 volume of Laemmli buffer and boiled for 10 min. After centrifugation, 20 ml of
the supernatant was used for SDS-PAGE (10% separation gel, 4.5% stacking
gel) and proteins were stained with Coomassie brilliant blue R250 (0.25%;
Sigma).
For Western blot analysis, protein extracts were prepared and analyzed by
SDS-PAGE as described above and blotted onto Immobilon P membrane (Mil-
lipore). Anti-Bap serum was diluted 1:2,500 with Tris-buffered saline (TBS) (50
mM Tris-HCl [pH 7.5], 150 mM NaCl) and immuno-absorbed with 5% skim-
milk. Alkaline phosphatase-conjugated goat anti-rabbit Immunoglobulin G (Sig-
ma) diluted 1:15,000 in TBS–5% skim milk was used and the subsequent chemi-
luminescence reaction (with CSPD [Roche]) was recorded.
Expression of the N-terminal region of Bap in E. coli. A 1,919-bp DNA
sequence corresponding to nucleotides (nt) 1 through 1919 of the bap gene was
amplified by PCR with primers bap-2m (59-GGGGGGCATATGGGAAATAA
ACAAGGTTTTTTACC-39) and bap-3c (59-GGGGGGATCCCCAACCTCGTC
AATGGTTAAGTCAGC-39) (NdeI and BamHI restriction sites are shown in
boldface type). The amplified product was restricted with NdeI and BamHI and
cloned in frame downstream from the His tag sequence in the pET-15b vector.
The nucleotide sequence of the cloned bap fragment was verified by sequence
analysis. Purified plasmid DNA was used to transform the expression host
BL21(DE3), and the fusion protein was produced as specified by the manufac-
turer (Novagen). After disrupting the cells by sonication, the recombinant pro-
tein was purified by immobilized metal affinity chromatography using a cobalt-
based resin (Clontech).
Production of rabbit polyclonal antiserum. Polyclonal antiserum to purified
recombinant protein was raised as previously described (43). For the initial dose
(day 1), 100 mg of antigen in complete Freund’s adjuvant was injected subcuta-
neously. Booster doses (50 mg) were administered intramuscularly on days 14
and 42 in incomplete adjuvant. Blood was collected from the marginal ear vein
at 2-week intervals after booster administration, and antibody titer in serum was
determined.
Experimental infection. A mouse foreign body infection model was used to
determine the role of bap in the pathogenesis of S. aureus. A total of 53 adult
male mice (Swiss-Albino, B&K Universal, Barcelona, Spain) were used. A 1-cm
segment of intravenous catheter (22G10; B. Braun) was aseptically implanted
into the subcutaneous interscapular space. Each group of nine mice was inocu-
lated with 1.5 3 105 CFU of either S. aureus V329 or the Bap-defective S. aureus
strain m3591. Three animals were euthanatized by cervical dislocation on days 4,
7, or 10 postinfection. The catheter was aseptically removed, placed in a sterile
microcentrifuge tube containing 1 ml of PBS, and vortexed at high speed for 3
min. The number of bacteria was determined by plate count. The experiment was
repeated three times.
In each experiment, an extra group of animals was inoculated with vehicle
(PBS) and served as a negative control. In addition, to exclude the possibility of
contamination, bacteria recovered at the end of the experimental period were
compared with the parental strains by coagulase DNA typing (21) and with
regard to growth in TSA-erythromycin, CRA colony morphology phenotype, and
biofilm formation capacity (see above).
Statistical analysis. A two-tailed Student’s t test was used to determine the
differences between groups in biofilm formation. A nonparametric test (Mann-
Whitney U test) was used to assess significant differences in bacterial recovery
within groups in primary adherence and experimental infection. For analysis of
the cure ratio, a two-by-two contingency table was produced and Fischer’s exact
test was applied. Differences were considered statistically significant when P was
,0.05 in all cases.
Nucleotide sequence accession number. The DNA sequence reported in this
article has been deposited in the GenBank nucleotide sequence database under
accession number AF288402.
RESULTS
Production and characterization of Tn917 mutants. Upon
transfer of plasmid pID408 into the adherent S. aureus strain
V329, a collection of approximately 4,000 random Emr Cms
transposon insertions was screened for their ability to form a
biofilm. Two mutants, designated m556 and m3591, had lost
the ability to form a biofilm (Fig. 1) and exhibited a growth rate
indistinguishable from that of the wild type. Southern hybrid-
ization analysis of EcoRI-digested chromosomal DNA using a
Tn917-specific probe revealed that each mutant had a single
transposon insertion (data not shown).
Sequencing of the DNA flanking the transposon insertion
sites in both mutants revealed that the transposon insertions
disrupted the same gene, but at different positions. When the
DNA sequences were compared with those in the GenBank
and the S. aureus databases using the BLAST program, no
significant similarity with any sequence was found.
The putative gene involved in biofilm formation was cloned
from a lamba genomic library as a 16-kb fragment detected by
hybridization to the region flanking the transposon insertion
site. The nucleotide sequence of this 16-kb fragment revealed
that the transposon disrupted an unusually large gene, desig-
nated bap (coding for a biofilm-associated protein, Bap), con-
sisting of 6,831 nt and harboring a potential ribosome-binding
site (TGAGG) located 9 nt upstream of the ATG initiation
codon. The presence of a putative promoter and transcription
terminator sequence upstream and downstream of bap sug-
gests that this gene is not part of an operon. Hence, polar
effects of the transposon insertion are unlikely. The deduced
amino acid sequence of Bap consists of 2,276 amino acids (aa),
with a theoretical molecular mass of ’239 kDa.
Bap expression allows and enhances biofilm formation. A
double band that migrated at a position corresponding to 230
and 240 kDa was reproducibly detected by SDS-PAGE of the
total protein extract from the wild-type bacteria but not from
the m556 mutant (Fig. 2A). Bands of similar mobility were also
detected in S. aureus strains which were complemented with
the bap gene in pBT2:Bap. In addition, a band of the expected
size was recognized by polyclonal antibodies raised against the
first 640 aa of Bap (Fig. 2B), strongly suggesting that the band
FIG. 1. Biofilm formation phenotype. Differences between the
wild-type strain V329 and mutants m556 and m3591 in the capacity to
form a 24-h biofilm on polystyrene microtiter plates after staining with
safranin. The ELISA plate colors correspond to OD490s of 1.3, 0.17,
and 0.18, respectively.
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present in the wild type and complemented strains is the prod-
uct of the bap gene.
Analysis of the capacity to form a biofilm (on a polystyrene
surface after 24 h) demonstrated that all strains expressing
Bap, including S. aureus SA113, a strain whose biofilm forma-
tion has been related to the ica product (PIA-PNSG), showed
an enhanced capacity to form a biofilm, implicating Bap in this
process (Fig. 3). Significant differences in adherence were de-
tected between the parental strain and its isogenic mutant, as
well as between noncomplemented and complemented strains
(P , 0.01). It is important to note that the capacity for biofilm
formation was not completely restored in the complemented
m556 mutant, although the expression level of the protein was
similar to that in the wild type.
Bap is involved in primary adherence and intercellular ad-
hesion. Primary adherence of S. aureus strains V329, m556,
SA113, and SA113Dica is illustrated in Fig. 4. S. aureus V329
adhered to polystyrene much more efficiently than the isogenic
bap mutant m556 and strains SA113 and SA113Dica. In addi-
tion, the presence of cell-to-cell clusters was observed in V329
and SA113 cultures (incubated overnight in TSB–0.25% glu-
cose) by phase-contrast microscopy (data not shown), but not
in the mutant m556 and SA113Dica cultures. Accumulation of
cell aggregates at the bottom of the tube was macroscopically
observed only in the case of wild type strains. These results
strongly suggest that Bap is not only involved in intercellular
adhesion and accumulation in multilayered cell clusters, as the
product of the ica operon does, but also in primary attachment
to an abiotic surface.
Relationship between Bap and PIA-PNSG. To determine
Bap–PIA-PNSG interaction we tested PIA-PNSG production
in Bap1 and Bap2 strains. The strain V329 showed a low level
of in vitro PIA-PNSG production. Similar results were ob-
tained whith other natural Bap1 strains (data not shown).
Inactivation of the bap gene in the mutant strain m556 reduced
the levels of PIA-PNSG (Fig. 5). Complementation of the
PIA-PNSG-producing strain SA113 with the bap gene strongly
increased PIA-PNSG accumulation (Fig. 5). As expected, PIA-
PNSG was no longer produced in the ica knockout strain
SA113Dica (Fig. 5).
Further phenotypic characterization of biofilm-defective
mutants. Consistent with the results on polystyrene microtiter
plates, the wild-type strain (V329) grown on CRA exhibited a
rough colony morphology typically associated with biofilm pro-
ducers, whereas mutants m556 and m3591 produced a smooth
colony morphology commonly found in non-biofilm-producing
strains (Fig. 6A). Phase-contrast microscopic observation of
late adherence to PVC plastic discs showed that the wild-type
strain produced multiple layers of cells almost completely cov-
ering the PVC surface (Fig. 6B). In contrast, very few cells of
the biofilm-defective mutant were attached to PVC plastic.
Macroscopic examination of biofilms in a glass container re-
vealed that upon 2 days of culture, the wild-type strain formed
an obvious biofilm on the glass surface, but the mutants did not
(Fig. 6C).
Structural features of Bap protein. Analysis of the Bap pri-
mary amino acid sequence revealed the presence of a typical
gram-positive amino-terminal signal sequence for extracellular
secretion (first 44 aa) and a putative carboxy-terminal segment
containing an LPXTG motif and a hydrophobic membrane-
spanning domain followed by a series of positively charged
residues typical of cell-wall-anchored surface proteins of gram-
positive bacteria (34) (Fig. 7A). Following the putative signal
peptide, the N-terminal region of Bap can be divided into two
regions. Region A (aa 45 to 360) contains two short repeats of
32 aa (repeats A1 and A2) separated by 26 aa (Fig. 7B). BlastP
searches of this region revealed no significant similarity scores
among GenBank sequences. Region B, the remaining part of
the N-terminal domain (aa 361 to 818), exhibited a significant
similarity with an Enterococcus faecalis surface protein (Esp)
(43), which is mostly found in infection-derived isolates.
The central region of Bap (aa 819 to 2147) begins with a
spacer region (aa 819 to 947) followed by 13 nearly identical
258-nt tandem repeat units encoding reiterations of an 86-aa
sequence (C repeats, aa 948 to 2139) (Fig. 7A). The C-repeat
region begins with a partial C-repeat sequence corresponding
to the last 37 aa of a C repeat and ends with a partial C-repeat
sequence corresponding to the 37 first aa of a C repeat (Fig.
7B). The C-repeat region accounts for 52% of the Bap protein,
and each repeat shows high sequence identity. BlastN searches
of the 258 nt encoding a C repeat reveals a strong similarity
with a partial GenBank sequence (PstI S. simulans, G. Thumm
FIG. 2. (A) SDS-PAGE of protein extracts of wild-type strain
V329, m556, RN4220, SA113, and the corresponding complemented
strains: m556 pBT2:Bap (m556, lane 1), RN4220 pBT2:Bap (RN4220,
lane 1), and SA113 pBT2:Bap (SA113, lane 1). Note that a double
protein band of 230 and 240 kDa is present in the wild-type strain as
well as in all the strains harboring plasmid pBT2:Bap. (B) Study of the
presence of Bap by Western blotting. An approximately 240-kDa band
is recognized by polyclonal antibodies against the first 640 aa of Bap
only in the wild-type strain V329 and complemented strains: m556
pBT2:Bap (m556, lane 1), SA113Dica pBT2:Bap (SA113Dica, lane
1), and SA113 pBT2:Bap (SA113, lane 1).
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and F. Go¨tz, accession number U66881), while BlastP searches
of the C repeats exhibited high similarity with extracellular
proteins from different species, including P. aeruginosa (E val-
ue: e-120; accession number AAG05263), Pseudomonas putida
(E value: 3e-94; accession number AF182515), Synechocystis
sp. (E value: 6e-94; accession number D63999), Salmonella
enterica serovar Typhi (E value: 1e-82; accession number
AF139831), and Enterococcus faecalis (E value: 5e-81; acces-
sion number AF034779).
The carboxy-terminal region of Bap comprises the D region
and the LPXTG motif (Fig. 7A). The D region (aa 2148 to
2208) consists of three short repeats of 18 aa followed by an
incomplete repeat comprising the first 7 aa of the D repeats
(Fig. 7B). LPXTG is a consensus cell wall anchor motif found
in most wall-associated surface proteins of gram-positive bac-
teria (34). BlastP searches of the D region revealed no signif-
icant similarity scores among GenBank sequences.
When the Bap protein was compared with products of S.
aureus genomes using the BLAST program, no significant sim-
ilarity with any sequence was found.
Distribution of the bap gene among staphylococcal species.
PCR amplification and Southern blot analysis using specific
probes for the bap gene revealed that bap is present in only 5%
of the 350 S. aureus bovine mastitis isolates tested. The pres-
ence of bap could not be detected in any of the 75 human S.
aureus isolates studied. All the strains harboring bap were
strong biofilm producers. Sequences that hybridized with the
bap probe were present in 10% of the 50 coagulase-negative
Staphylococcus isolates tested from animals with bovine mas-
titis (data not shown).
Experimental infection. Bap contributed to the pathogenesis
of S. aureus in the murine catheter-induced infection model
(Fig. 8). Although at day 4 postinoculation differences between
wild-type and mutant strains in the number of recovered bac-
FIG. 3. pBT2:Bap complementation studies involving biofilm formation in biofilm-defective mutant m556, non-biofilm-forming strain RN4220,
and biofilm-forming strain SA113 and its ica-defective mutant SA113Dica. Biofilm formation capacity differences correspond to 24-h biofilm
formed on polystyrene microtiter plates after staining with 0.1% safranin. The ELISA plates and mean OD490s obtained are shown. (A) ELISA
wells corresponding to wild type V329, m556 (2) and m556 pBT2:Bap (1), RN4220 (2) and RN4220 pBT2:Bap (1), SA113Dica (2) and
SA113Dica pBT2:Bap (1), and SA113 (2) and SA113 pBT2:Bap (1). (B) Mean optical density. Bars represent the mean values, and error bars
represent the standard errors of the means (n 5 5). Significant differences in adherence (P , 0.01) were noted between complemented and
noncomplemented strains, as well as between the wild type and isogenic mutants.
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teria per catheter were non significant, at day 7 postinocula-
tion, the number of recovered bacteria (CFU) was 1.2 3 106
and 2.8 3 105 for the wild-type and mutant strains, respectively
(P . 0.05). This difference increased by day 10, when the
values were 1.7 3 106 and 3 3 104 CFU, respectively (P ,
0.05).
The analysis of the cure ratio (number of animals infected/
number of animals inoculated) (Table 1) showed that animals
infected with the wild-type strain developed a persistent infec-
tion (six of nine animals infected at day 10). However, animals
inoculated with the mutant strain were more capable of elim-
inating the infection (two of nine animals infected at day 10).
These results indicate that Bap is an important factor deter-
mining the persistence of infection.
DISCUSSION
In S. epidermidis, several surface proteins involved in biofilm
formation have been described, three of which (SSP1, SSP2,
and the AtlE autolysin [19, 45]) contribute to the primary
attachment, and the other, a 140-kDa protein mediating inter-
cellular adhesion, has been proposed as essential for accumu-
lation of sessile bacteria on glass or polystyrene surfaces (22).
The absence of homology among these proteins strongly sug-
gests that staphylococci may use different approaches to form
a biofilm. To our knowledge, data presented in this report
describe the first S. aureus surface protein (Bap) directly in-
volved in biofilm formation on abiotic surfaces in the absence
of host plasma constituents.
To identify Bap, we have used the standard biofilm assay on
microtiter plates for the screening of transposon mutants un-
able to adhere to the polystyrene surface. Surprisingly, in con-
trast to similar studies with other microorganisms like P.
aeruginosa (35), E. coli (38), and Vibrio cholerae (47), where
several genes were found to be involved in the biofilm forma-
tion process, this assay allowed identification of only two mu-
tants in which the transposon affected the same 6,831-bp open
reading frame designated bap.
The bap gene displayed little sequence similarity with known
genes. However, the 2,276-aa bap product displayed an orga-
nizational similarity with an outer membrane protein of P.
putida involved in adhesion to seeds (12) and with a surface
FIG. 4. Primary attachment assay. Significant (P , 0.01) differ-
ences were detected between wild-type strain V329 and isogenic mu-
tant m556. No differences were found between S. aureus SA113 and
isogenic mutant SA113Dica. Bars represent the mean values, and error
bars represent the standard errors of the means (n 5 3).
FIG. 5. Dot blot analysis of S. aureus PIA-PNSG acummulation
induced by Bap expression. S. aureus V329 (blot A1) and m556 (blot
B1) produced low levels of PIA-PNSG. Complementation of S. aureus
SA113 with pBT2-Bap plasmid strongly increased the levels of PIA-
PNSG (blot B2) with respect to the wild-type strain (blot A2). PIA-
PNSG was not detected in S. aureus SA113Dica (blot A3).
FIG. 6. Phenotypic differences between the wild-type strain V329
and the defective mutant m556. (A) CRA colony morphology; (B)
capacity to form a 24-h biofilm on PVC plastic, as observed by phase-
contrast microscopy (magnification, 31,000); (C) capacity to form a
48-h biofilm on the surface of a glass container (visual observation).
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protein of E. faecalis (Esp) of unknown function (43), but
whose presence is highly correlated with the ability of this
bacteria to produce a biofilm on abiotic surfaces (our unpub-
lished results). The most remarkable feature of Bap is the
presence of an extensive repeat region, in which the repeats
are identical even at the nucleotide level. Although the bio-
logical function of the repeats has not been established, it is
tempting to speculate that this region could serve to project the
amino-terminal part of the protein from the cell surface and to
promote interaction with abiotic surfaces, host cell compo-
nents, or other bacteria. Analogous long repeats have been
described in the alpha C protein of group B streptococci (46),
where addition or deletion of repeat units leads to the expres-
sion of variant proteins which allow bacteria to escape the host
immune response (27). Similar pathogenic mechanisms might
occur in different Bap1 strains, in which a variable number of
C repeats can be found in the structure of the bap gene.
Primary attachment, intercellular aggregation, and biofilm
formation studies showed that Bap promotes primary attach-
ment as well as the second step of biofilm formation, where
intercellular adhesion plays an important role. In this context,
since complementation of S. aureus SA113 with bap resulted in
a significantly increased ability to form a biofilm and PIA-PNSG
accumulation, it is tempting to speculate that PIA-PNSG and Bap
may cooperatively affect cell-to-cell aggregation during the bio-
film formation process. A possible explanation of the observation
that biofilm formation capacity was not completely restored in the
complemented m556 mutant is that the insertion of the transpo-
son in mutant m556 resulted in the production of a truncated
protein lacking the last 15 aa, and therefore the protein would
be unable to anchor to the cell wall. The soluble truncated Bap
protein may cover the abiotic surface and compete with the
cell-associated Bap for the interaction with the abiotic surface.
CRA has been used to discriminate by colony morphology
between biofilm and non-biofilm-forming strains of S. aureus
(2, 6) and S. epidermidis (48), since they produce rough and
FIG. 7. (A) Structural analysis of Bap. S represents the signal sequence. The positions of the LPXTG motif and the A, B, C, and D domains
are shown. Region A (aa 45 to 360) contains two short repeats of 32 aa (A1 and A2) separated by 26 aa. Region B (aa 361 to 818) represents the
remaining part of the N-terminal domain. A spacer region (aa 819 to 947) followed by region C (aa 948 to 2139) consisting of 258-nt tandem repeats
constitutes the central domain of Bap. The carboxy-terminal region of Bap consists of region D (aa 2148 to 2208), which contains three short
repeats of 18 aa followed by an incomplete D repeat, and the LPXTG motif. (B) Alignment of the amino acid residues within repeat blocks A,
C, and D of the Bap protein. Substitutions are shown in boldface type.
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smooth colonies, respectively. Congo red interacts with several
proteins and proteinaceous fibrillar structures, such as curli
fimbriae from E. coli (17) and the type III secretion machinery
of Shigella flexneri (4). In the case of bap-harboring S. aureus,
loss of the Bap protein resulted in transformation of the rough
colony morphology (of the wild-type V329 strain) into the
smooth colony morphology (of the m556 mutant). A similar
phenotypic variation has been described in S. epidermidis
strains deficient in the production of PIA-PNSG (the ica prod-
uct) (48) and S. aureus strain SA113Dica (our unpublished
results). When the expression of bap was restored in comple-
mented strains, the rough phenotype appeared, suggesting the
implication of Bap in this phenotypic variation. Why the defi-
ciency in either the polysaccharide intercellular adhesin (PIA-
PNSG) or a surface protein (Bap) results in the same pheno-
typic change is unknown.
Animal models have been useful to study the importance of
different genes in the pathogenesis and virulence of S. aureus
(30, 31). In this report, we used a mouse foreign body infection
model to evaluate the role of Bap and the resulting biofilm
formation process in the pathogenesis of S. aureus. Differences
between the Bap-deficient mutant S. aureus m3591 and the
parental strain in the capacity to colonize the catheter became
more obvious at late stages of infection (by day 10), when the
mutant strain showed a decreased persistence relative to the
wild type. In the closely related species S. epidermidis, the
expression of specific bacterial cell surface components ap-
pears to hinder the interaction of particular bacterial cell re-
ceptors with host proteins (5). In our model, the catheter may
have become rapidly coated in vivo by host proteins after
implantation and Bap might have hindered the interaction
between bacterial receptors and the host proteins on the cath-
eter. This may explain why a Bap-deficient mutant may be
more prevalent than the wild-type strain at the initial stages of
infection (up to day 4). Later on (days 7 to 10), biofilm for-
mation would be strongly enhanced by Bap as infection pro-
ceeds, by promoting cell-to-cell interactions, bacterial accumu-
lation, and persistence of infection.
In conclusion, this study describes a novel protein of S.
aureus involved in biofilm formation on abiotic surfaces. At-
tachment to abiotic surfaces might not be necessarily related to
attachment to biotic surfaces. In fact, there are examples that
support the idea that bacterial biofilm formation can proceed
through divergent pathways, depending on whether or not
bacteria settle on a surface or in an environment that can
provide nutrients (47). Other results demonstrate that the
same factors may be involved in attachment to both types of
surfaces (12). Probably, during the development of infections
such as subclinical mastitis, biofilm formation could be an
efficient way of persisting in the microenvironment of the ud-
der, where shear forces arise during milking (6). The presence
of Bap in S. aureus strains responsible for subclinical mastitis
suggests that Bap may enhance intramammary adherence and
biofilm formation, leading to the inefficacy of antibiotic treat-
ment against biofilm bacteria and chronicity. Further studies to
demonstrate this hypothesis are warranted.
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